EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.
Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.
The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.
EKF Diagnostics Holdings plc
Julian Baines, CEO
Richard Evans, Finance Director and COO |
00 44 29 2071 0570
|
N+1 Singer
Alex Price / Alex Laughton-Scott |
00 44 20 7496 3000 |
|
Walbrook PR Limited
Paul McManus
Lianne Cawthorne
|
00 44 20 7933 8780 or ekf@walbrookpr.com
00 44 7980 541 893
00 44 7584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT")
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
EKF Diagnostics Holdings plc
|
|
b)
|
LEI
|
213800DXTF3EAUK1AR05
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrumentIdentification code
|
Ordinary shares of 1p each (“Ordinary Shares”) ISIN Code: GB0031509804
|
|
b)
|
Nature of the transaction
|
Acquisition of shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
19.5p
|
8,000,000
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
n/a
|
|
e)
|
Date of the transaction
|
20 March 2017
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
|
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.